Hydroxy Compound Active Ingredients TRIZ Cases

A protocol combining magnesium, inositol, and N-acetylcysteine to inhibit voltage-dependent calcium channels.

Tryptophan-derived feed additives modulate gastrointestinal metabolite ratios to resolve inflammation and circadian rhythm disruptions in confined livestock.

Hexane fraction of watermelon sprout containing phytol and lutein inhibits cancer cell growth while sparing healthy cells.

Co-precipitate of stilbene polyphenols and lamellar anionic solids improves bioavailability and photostability for pharmaceutical formulations.

Oxidized cholesterol compounds restore membrane fluidity to treat myocardial depression without high-dose beta-adrenergic agonist toxicity.

Replacing sucrose with allulose eliminates lengthy dissolution times and high blood glucose risks while preserving sweet taste.

Segmenting diagnostic criteria via the P.R.I.C.E. acronym prevents misdiagnosis and enables targeted treatment with extended release clonidine or guanfacine.

Enteric soft capsule shell resists gastric acid to deliver omega-3 fatty acids, eliminating fishy odors and gastric disturbances.

Synthetic derivatives Sandalore and Brahmanol activate the olfactory receptor OR2AT4 to promote cell proliferation.

Combining CBD, melatonin, and AKBA overcomes inadequate monotherapies by leveraging synergistic effects to significantly reduce PDAC cell viability.

Microparticle-enriched protein biomarkers resolve low signal-to-noise ratios in maternal serum to improve diagnostic accuracy.

Digoxin inhibits TGF-beta-induced fibronectin production, addressing inadequate efficacy and toxicity of current cancer and fibrosis therapies.

Acidic oral composition with curcuminoids and buffering agents increases female calf birth rates in bovines.

A (+)-syringaresinol composition promotes SIRT1 expression to protect cardiomyocytes from oxidative stress.

Controlled polymerization creates PVP-PLA block copolymers that encapsulate APIs in stable micelles, improving drug loading capacity.

Combining spliceosome modulators with BCL2 inhibitors targets anti-apoptotic proteins in cancer cells.

Microparticles composed of saturated vegetable oils and polyphenols scavenge free radicals from gas and semi-liquid phases.

Segmented nanoparticle architecture mitigates energy back-transfer, enabling brighter luminescence at lower excitation powers without thermal toxicity.

Teratogenic pharmaceutical compounds activate destructive pathways in cancer stem cells, reducing recurrence by eliminating persistent disease populations.

A rapid-deposition thin-film composition uses non-aqueous solvents to form a flexible protective barrier on wound surfaces.

Composite edible oil formulation addresses joint soreness and insomnia by combining purified cannabinoids at defined concentrations.

Parameter changes optimize dosing and routes while preliminary action selects patients, reducing side effects.

Applying antibacterial ointment before microneedling prevents bacterial spread while enabling transdermal absorption of anti-inflammatory agents.

Aryl alkanone compounds reverse skin cancer proliferation by regulating gene expression levels, reducing toxicity to normal cells.

Distinct glycerol phases in silicone matrices prevent initial burst effects and achieve zero-order release kinetics.

Isothiocyanate derivatizing agents react with polyvinyl alcohol hydroxyl groups to attach functional labels and bioactive molecules directly to the polymer chain.

Lateral tunneling enables outward lip turning while minimizing filler quantity.

Dietary supplement activates B cells and strengthens mucosal barriers using yeast fermentate and herbal extracts while removing common allergens.

Combines NFκB-inhibitors with low IC50 anti-inflammatory compounds to reduce inflammatory cytokine production.

Dianhydrogalactitol crosses the blood-brain barrier to suppress tumor growth in diffuse intrinsic pontine gliomas.

Disodium EDTA chelates metal ions to prevent oxidation, maintaining emulsion clarity while reducing injection pain.

A cantharidin composition uses a non-aqueous solvent to enhance penetration depth and retention within skin lesions.

Agar gel combined with cyclodextrin stabilizes carotenoid particles, preventing exudation during tableting and storage without animal-derived allergens.

A chewable lozenge formulation containing plant sterol ester and triglyceride fat delivers active ingredients without water.

Segmented enteric-coated L-menthol particulates prevent premature gastric release and ensure consistent intestinal absorption.

Genetically modified E. coli expressing Streptomyces UGT enzymes catalyze glucuronide synthesis from phenolic substrates.

A pharmaceutical composition combining vitamin D with hydroxytyrosol and oleuropein stimulates osteoblast differentiation.

Nanoscale particle segmentation accelerates tetrahydrocannabinol dissolution, resolving delayed oral absorption and erratic therapeutic onset.

Gamitrinib combined with MAPK inhibitors disrupts mitochondrial biogenesis to induce apoptosis in melanoma cells.

Brønsted base deprotonation converts insoluble cannabinoids into water-soluble anions, resolving beverage flavor and bioavailability bottlenecks.

Hot melt extrusion converts crystalline cannabinoids into an amorphous solid dispersion within a carrier matrix, improving solubility and bioavailability.

Administering a maternal composition with defined nutrient ranges increases breast milk quality to address insufficient concentrations for preterm infant needs.

A nutraceutical composition combining myo-inositol, D-chiro-inositol, and resveratrol to address metabolic disorders in polycystic ovary syndrome.